Lulican Lotion contains Luliconazole 1% w/v, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and certain molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This lotion is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis. Its once-daily application enhances patient compliance and treatment efficacy. Lulican Lotion is applied topically to the affected area after cleansing and drying the skin, typically for a duration of 1 to 2 weeks depending on the severity and site of infection. Common adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. The lotion should be used with caution in patients with known hypersensitivity to Luliconazole or other imidazole antifungals. It is not intended for use on mucous membranes, eyes, or open wounds. Lulican Lotion offers an effective and convenient therapeutic option for managing superficial dermatophytic infections, promoting rapid symptom resolution and fungal eradication.